More on NBP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.63 |
|
|||
| Open | $1.62 | ||||
| 52 Wk High | $6.95 | ||||
| 52 Wk Low | $6.95 | ||||
| Day High | $1.65 | ||||
| Day Low | $1.60 | ||||
| P/E | 0.75 | ||||
| EPS | $2.14 | ||||
| Volume | 197,630 | ||||
- Form 144 NovaBridge Biosciences Filed by: Dennis Phillip Andrew
- Form 4 NovaBridge Biosciences For: Sep 09 Filed by: Cao Sean Wuxiong
- Form 3 NovaBridge Biosciences For: Sep 08 Filed by: Dewhurst Martin William
- NovaBridge Biosciences to Participate in September Investor Conferences
- Form 4 NovaBridge Biosciences For: Aug 22 Filed by: Lenz Robert A.
- H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP)
- NovaBridge Biosciences (NBP) PT Lowered to $110 at Morgan Stanley
- Form 6-K NovaBridge Biosciences For: Jun 30
- Form 6-K NovaBridge Biosciences For: Aug 20
- NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
Entities mentioned with NBP
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- S1 | View Related Stories »
- Show More...
